Literature DB >> 30613920

High Expression of Long Noncoding RNA HOTAIRM1 is Associated with the Proliferation and Migration in Pancreatic Ductal Adenocarcinoma.

Yongyun Luo1, Yaqin He2, Xiaoping Ye3, Jianjun Song1, Qi Wang1, Yukui Li4, Xiaoliang Xie5,6.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an incurable malignancy. Long noncoding RNA (LncRNA) HOTAIRM1 (HOX antisense intergenic RNA myeloid 1) has been shown to play important roles in the progression of several type cancers. However, the exact role of HOTAIRM1 in PDAC development remains largely unknown. This study aims to evaluate the potential function of HOTAIRM1 in the development and progress of PDAC. HOTAIRM1 expression was measured by RT-qPCR in forty seven paired human PDAC tissues and five PDAC cell lines. SW1990 and PANC-1 cells were transfected with siHOTAIRM1 to achieve HOTAIRM1 silence. MTT assay and colony formation assay were used to detect the effect of HOTAIRM1 knockdown on cell proliferation. The impact of HOTAIRM1 silence on cell cycle and apoptosis was assessed by flow cytometry assay. Transwell migration assay was performed to explore the influence of HOTAIRM1 downregulation on the migratory potential of PDAC cells. Western blot assay was applied to determine the expression changes of cell cycle, apoptosis, and migration-related genes before and after downregulating HOTAIRM1. HOTAIRM1 expression was abnormally upregulated in PDAC tissues and cells when compared with the control samples, and was positively associated with the expression of KRAS gene mutation. In vitro functional experiments, HOTAIRM1 expression was significantly downregulated by transfection with siHOTAIRM1 in SW1990 and PANC cell lines. HOTAIRM1 knockdown attenuated cell proliferation by inducing cell cycle arrest at G0/G1 phase, promoted cell apoptosis, and inhibited cell migration in PDAC cells by regulating related-genes expression. In conclusion, HOTAIRM1 plays a critical role in PDAC progression, which may be a novel diagnostic and rational therapeutic target for the treatment of pancreatic ductal adenocarcinoma.

Entities:  

Keywords:  HOTAIRM1; Migration; Pancreatic ductal adenocarcinoma; Proliferation

Mesh:

Substances:

Year:  2019        PMID: 30613920     DOI: 10.1007/s12253-018-00570-4

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  47 in total

Review 1.  Long non-coding RNAs: insights into functions.

Authors:  Tim R Mercer; Marcel E Dinger; John S Mattick
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

Review 2.  Long noncoding RNAs and human disease.

Authors:  Orly Wapinski; Howard Y Chang
Journal:  Trends Cell Biol       Date:  2011-05-06       Impact factor: 20.808

3.  Combinations with checkpoint inhibitors at wavefront of cancer immunotherapy.

Authors:  Megan Cully
Journal:  Nat Rev Drug Discov       Date:  2015-06       Impact factor: 84.694

4.  Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells.

Authors:  Yongguo Shi; Jianwei Lu; Jing Zhou; Xueming Tan; Ye He; Jie Ding; Yun Tian; Li Wang; Keming Wang
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

5.  Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis.

Authors:  Yi Chen; Jian-Jin Wu; Xian-Bin Lin; Yi Bao; Zhen-Hua Chen; Cheng-Ran Zhang; Zheng Cai; Jue-Yu Zhou; Mao-Hua Ding; Xiao-Jun Wu; Wei Sun; Jun Qian; Lei Zhang; Lei Jiang; Guo-Han Hu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma.

Authors:  Yue-Chao Ding; Wei Yu; Chao Ma; Qian Wang; Chang-Shan Huang; Tao Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

7.  Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells.

Authors:  Xueqing Zhang; Sherman M Weissman; Peter E Newburger
Journal:  RNA Biol       Date:  2014-04-24       Impact factor: 4.652

8.  Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA.

Authors:  Nicolas Léveillé; Carlos A Melo; Koos Rooijers; Angel Díaz-Lagares; Sonia A Melo; Gozde Korkmaz; Rui Lopes; Farhad Akbari Moqadam; Ana R Maia; Patrick J Wijchers; Geert Geeven; Monique L den Boer; Raghu Kalluri; Wouter de Laat; Manel Esteller; Reuven Agami
Journal:  Nat Commun       Date:  2015-03-27       Impact factor: 14.919

9.  Postnatal telomere dysfunction induces cardiomyocyte cell-cycle arrest through p21 activation.

Authors:  Esther Aix; Óscar Gutiérrez-Gutiérrez; Carlota Sánchez-Ferrer; Tania Aguado; Ignacio Flores
Journal:  J Cell Biol       Date:  2016-05-30       Impact factor: 10.539

10.  OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo.

Authors:  Xiao Zhi; Wei Chen; Fei Xue; Chao Liang; Bryan Wei Chen; Yue Zhou; Liang Wen; Liqiang Hu; Jian Shen; Xueli Bai; Tingbo Liang
Journal:  Oncotarget       Date:  2015-09-22
View more
  11 in total

1.  Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.

Authors:  Yanping Wang; Heather Hardin; Ying-Hsia Chu; Karla Esbona; Ranran Zhang; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

2.  Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.

Authors:  Ling Zhang; Jin Zhang; Shujing Li; Yanyan Zhang; Yun Liu; Jian Dong; Wenjun Zhao; Bo Yu; Huifang Wang; Jing Liu
Journal:  RNA Biol       Date:  2020-09-20       Impact factor: 4.652

Review 3.  The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer.

Authors:  Jichuan Xu; Jian Xu; Xinyuan Liu; Jianxin Jiang
Journal:  Cell Death Discov       Date:  2022-06-14

Review 4.  Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review.

Authors:  Hilda Samimi; Sayed Mahmoud Sajjadi-Jazi; Soroush Seifirad; Rasha Atlasi; Habibollah Mahmoodzadeh; Mohammad Ali Faghihi; Vahid Haghpanah
Journal:  Cancer Cell Int       Date:  2020-07-29       Impact factor: 5.722

5.  LncRNA HOTAIRM1/HOXA1 Axis Promotes Cell Proliferation, Migration And Invasion In Endometrial Cancer.

Authors:  Xianli Li; Li Pang; Zhuo Yang; Jing Liu; Weishan Li; Danbo Wang
Journal:  Onco Targets Ther       Date:  2019-12-13       Impact factor: 4.147

6.  HOTAIRM1 Promotes Malignant Progression of Transformed Fibroblasts in Glioma Stem-Like Cells Remodeled Microenvironment via Regulating miR-133b-3p/TGFβ Axis.

Authors:  Haiyang Wang; Haoran Li; Qianqian Jiang; Xuchen Dong; Suwen Li; Shan Cheng; Jia Shi; Liang Liu; Zhiyuan Qian; Jun Dong
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

Review 7.  Three-Dimensional Genome Organization in Breast and Gynecological Cancers: How Chromatin Folding Influences Tumorigenic Transcriptional Programs.

Authors:  Stephanie I Nuñez-Olvera; Jonathan Puente-Rivera; Rosalio Ramos-Payán; Carlos Pérez-Plasencia; Yarely M Salinas-Vera; Lorena Aguilar-Arnal; César López-Camarillo
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

8.  Identification of New Potential LncRNA Biomarkers in Hirschsprung Disease.

Authors:  Ana Torroglosa; Leticia Villalba-Benito; Raquel María Fernández; Berta Luzón-Toro; María José Moya-Jiménez; Guillermo Antiñolo; Salud Borrego
Journal:  Int J Mol Sci       Date:  2020-08-02       Impact factor: 5.923

9.  The HOTAIRM1/miR-107/TDG axis regulates papillary thyroid cancer cell proliferation and invasion.

Authors:  Dan Li; Li Chai; Xiaqing Yu; Yingchun Song; Xuchao Zhu; Suyun Fan; Wen Jiang; Tingting Qiao; Junyu Tong; Simin Liu; Lihong Fan; Zhongwei Lv
Journal:  Cell Death Dis       Date:  2020-04-08       Impact factor: 8.469

10.  The long noncoding RNA HOTAIRM1 controlled by AML1 enhances glucocorticoid resistance by activating RHOA/ROCK1 pathway through suppressing ARHGAP18.

Authors:  Liang Liang; Wenbin Gu; Meng Li; Ran Gao; Xin Zhang; Chongye Guo; Shuangli Mi
Journal:  Cell Death Dis       Date:  2021-07-14       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.